Spinal Fusion Devices Market Size & Share to See Modest Growth Through 2026embed
Spinal fusion devices are used in spinal surgeries for patients suffering from various spinal diseases such as degenerative disc disease (DDD) and herniated disc. Spinal fusion devices are implanted into the spinal cord of the patient.
Spinal Fusion Devices Market Size & Share to See Modest Growth Through 2026 Spinal Fusion Devices Market, by Device Type (Spinal Plating Systems, Interbody Cages, and Pedicle Screw Systems), by Procedure Type (Cervical Spine, Thoracic spine, and Lumbar Spine), by End User (Hospitals, Ambulatory Surgical Center, Orthopedic Center, and Others), and by Region - Global Forecast to 2025 Spinal fusion devices are used in spinal surgeries for patients suffering from various spinal diseases such as degenerative disc disease (DDD) and herniated disc. Spinal fusion devices are implanted into the spinal cord of the patient. The U.S. Food & Drug Administration (FDA) has placed spinal fusion devices under Class II of medical devices category. Moderate to severe spine problems need to be treated with surgical approach such as spinal fusion wherein the spinal vertebrae are either removed and fixated with implants or fused with the help of various fusion methods. Quality of life can be improved by spinal fusion surgeries. Rising prevalence of spinal cord diseases is expected to increase adoption of these surgeries. Click To Read More On Spinal Fusion Devices Market. Market Dynamics Frequent approval from regulatory bodies to latest spinal fusion devices is expected to be the major driver for growth of global spinal fusion devices market over the forecast period. In 2016, Spineart Geneva SA received US Food and Drug Administration (FDA) clearance for its first range of titanium interbody, named - JULIET Ti PO, OL and TL interbody systems. The JULIETTi PO, OL and TL interbody systems are the range of titanium interbody implants. It include a full range of sizes to for diverse anatomies. The smooth bullet-shaped nose, lateral sides and chamfers of the implant are polished to preserve endplates, nerve roots, and soft tissues during insertion. The Ti-LIFE Technology micro-porous scaffold mimics the bone trabecular structure, which enables cell colonization and promotes bone ingrowth. In 2016, Centinel Spine, Inc. received U.S. FDA approval for STALIF L Minimally-Invasive Lateral Integrated Interbody System. It has advantages in minimally-invasive spinal fusion surgery. Furthermore, increasing prevalence of spinal disorder is also expected to increase demand for spinal fusions devices and hence is expected to drive spinal fusion devices market growth in near future. Ask For Sample Copy Of This Business Research Report : https://www.coherentmarketinsights.com/insight/request-sample/1211 Rapid product launch and frequent approval of novel spinal fusion devices are expected to drive growth of the global spinal fusion market In 2015, Aesculap Implant Systems, a division of B. BRAUN MELSUNGEN AG, launched Modulift Vertebral Body Replacement System (VBR). It is the latest generation of expandable cage technology. In 2017, Stryker’s Spine division launched Serrato pedicle screw, a unique dual-lead screw intended for use in the non-cervical spine. In 2016, Stryker launched Aero-C Cervical Stability System at the meeting of the American Academy of Orthopedic Surgeons in Orlando. Entry of these novel products in market is expected to support the growth of global spinal fusion devices market in near future. Furthermore, frequent approvals of innovative products is also expected to drive market growth. Competitive Landscape Key players operating in global spinal fusion devices market include Zimmer Biomet Holdings, Inc., Inc., Stryker Corporation, Inc., Exactech, Inc., Orthofix International N.V., Globus Medical, Inc., NuVasive, Inc., Medtronic Plc., Depuy Synthes, B. Braun Melsungen AG, Wenzel Spine, Inc., K2M Group Holdings, Inc., Centinel Spine, Inc., and Spineart Geneva SA. Increasing prevalence of spinal deformities is expected to drive growth of the global spinal fusion device market Factors responsible for spinal deformities include weight, diet, smoking, and other lifestyle factors. Early onset of degenerative spinal changes is attributed to the toxins in cigarette smoke damaging the cartilage of spine. According to World Health Organization (WHO), more than 1.1 billion people smoked tobacco in 2015 worldwide. According to a study published in SpineUniverse in 2017, disc herniation is the most common indication for spinal surgery, and around 75% of all spinal surgeries were performed for herniated disc. Increasing prevalence of spinal deformities due to unhealthy lifestyle and high chances of disc herniation are expected to drive growth of the spinal fusion devices market in near future. About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1–206–701–6702 Email: [email protected]